“COMPARATIVE PHARMACOECONOMIC EVALUATION OF THE USE OF AFATINIB AND GEFITINIB IN THERAPY FOR LUNG CANCER”. 2017. Voprosy Onkologii 63 (1): 38-51. https://doi.org/10.37469/0507-3758-2017-63-1-38-51.